Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Verofylline (Verofyllinum) is an orally available, long-acting, multiacting, methylxanthine-substituted bronchodilator with inhibitory effects on PDE4 for the treatment of asthma disease research obesity.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 33,500 | |||
5 mg | 在庫あり | ¥ 80,500 | |||
10 mg | 在庫あり | ¥ 122,000 | |||
25 mg | 在庫あり | ¥ 197,500 | |||
50 mg | 在庫あり | ¥ 271,000 | |||
100 mg | 在庫あり | ¥ 365,000 | |||
500 mg | 在庫あり | ¥ 732,500 |
説明 | Verofylline (Verofyllinum) is an orally available, long-acting, multiacting, methylxanthine-substituted bronchodilator with inhibitory effects on PDE4 for the treatment of asthma disease research obesity. |
別名 | CK 0383, Verofilina, CK-0383, Verofyllinum, CK0383 |
分子量 | 250.3 |
分子式 | C12H18N4O2 |
CAS No. | 66172-75-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 60 mg/mL (239.71 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Verofylline 66172-75-6 Metabolism PDE CK 0383 Verofilina CK-0383 Verofyllinum CK0383 Inhibitor inhibitor inhibit